Gilead Sciences Investor

Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.


Technology: CAR-T therapy, Cell-based gene therapy, Cell_Therapies, Others
Industry: Longevity Industry 2022, Public
Headquarters: Foster City, California, United States
Founded Date: 1987-06-22
Employees Number: 10001+
Funding Status: IPO
Number Of Exits: 11
Acquisitions Number: Made Acquisitions
Investors Number: 1
Estimated Revenue: $1B to $10B
Last Funding Date: 1988-01-01
Last Funding Type: Seed

Visit Website
Register and Claim Ownership